X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK vs SUN PHARMA - Comparison Results

MERCK    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK SUN PHARMA MERCK/
SUN PHARMA
 
P/E (TTM) x 50.9 28.3 180.0% View Chart
P/BV x 7.6 3.0 256.6% View Chart
Dividend Yield % 0.4 0.4 104.8%  

Financials

 MERCK   SUN PHARMA
EQUITY SHARE DATA
    MERCK
Dec-17
SUN PHARMA
Mar-18
MERCK/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,358701 193.8%   
Low Rs933433 215.4%   
Sales per share (Unadj.) Rs665.0110.4 602.4%  
Earnings per share (Unadj.) Rs56.611.0 515.3%  
Cash flow per share (Unadj.) Rs72.517.2 420.7%  
Dividends per share (Unadj.) Rs15.002.00 750.0%  
Dividend yield (eoy) %1.30.4 371.2%  
Book value per share (Unadj.) Rs441.7158.8 278.2%  
Shares outstanding (eoy) m16.602,399.26 0.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.75.1 33.5%   
Avg P/E ratio x20.251.6 39.2%  
P/CF ratio (eoy) x15.832.9 48.0%  
Price / Book Value ratio x2.63.6 72.6%  
Dividend payout %26.518.2 145.5%   
Avg Mkt Cap Rs m19,0111,360,021 1.4%   
No. of employees `0001.517.8 8.7%   
Total wages/salary Rs m1,69653,671 3.2%   
Avg. sales/employee Rs Th7,150.014,890.9 48.0%   
Avg. wages/employee Rs Th1,098.73,017.1 36.4%   
Avg. net profit/employee Rs Th608.21,480.6 41.1%   
INCOME DATA
Net Sales Rs m11,040264,895 4.2%  
Other income Rs m2408,388 2.9%   
Total revenues Rs m11,279273,282 4.1%   
Gross profit Rs m1,37656,081 2.5%  
Depreciation Rs m26414,998 1.8%   
Interest Rs m05,176 0.0%   
Profit before tax Rs m1,35244,295 3.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m170-9,505 -1.8%   
Tax Rs m5838,452 6.9%   
Profit after tax Rs m93926,338 3.6%  
Gross profit margin %12.521.2 58.9%  
Effective tax rate %43.119.1 225.9%   
Net profit margin %8.59.9 85.6%  
BALANCE SHEET DATA
Current assets Rs m7,523316,359 2.4%   
Current liabilities Rs m2,253198,643 1.1%   
Net working cap to sales %47.744.4 107.4%  
Current ratio x3.31.6 209.7%  
Inventory Days Days5295 55.0%  
Debtors Days Days41108 37.7%  
Net fixed assets Rs m1,240213,178 0.6%   
Share capital Rs m1662,399 6.9%   
"Free" reserves Rs m7,167378,606 1.9%   
Net worth Rs m7,333381,006 1.9%   
Long term debt Rs m017,721 0.0%   
Total assets Rs m9,912643,028 1.5%  
Interest coverage xNM9.6-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.10.4 270.4%   
Return on assets %9.54.9 193.3%  
Return on equity %12.86.9 185.3%  
Return on capital %20.810.0 207.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,01540,816 2.5%   
Fx outflow Rs m3,04330,143 10.1%   
Net fx Rs m-2,02810,673 -19.0%   
CASH FLOW
From Operations Rs m53739,072 1.4%  
From Investments Rs m-476-33,708 1.4%  
From Financial Activity Rs m-220-15,393 1.4%  
Net Cashflow Rs m-160-7,359 2.2%  

Share Holding

Indian Promoters % 0.0 63.7 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 5.1 354.8%  
FIIs % 1.0 23.0 4.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 8.3 350.6%  
Shareholders   28,591 133,026 21.5%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK With:   TORRENT PHARMA  ALKEM LABORATORIES  DIVIS LABORATORIES  SANOFI INDIA  ALEMBIC PHARMA  

Compare MERCK With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 222 Points Lower; Energy and Telecom Stocks Witness Selling(Closing)

Indian share markets witnessed most of the selling pressure during closing hours and ended their trading session lower.

Related Views on News

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, SUN PHARMA has posted a net profit of Rs 1 bn (down 110.7% YoY). Sales on the other hand came in at Rs 69 bn (up 4.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MERCK SHARE PRICE


Mar 22, 2019 03:35 PM

TRACK MERCK

COMPARE MERCK WITH

MARKET STATS